Compositions and methods for the management of hyperproliferative dermatological conditions
US7582314B2 · kind B2 · utility
2Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2004 |
| Grant date | Sep 1, 2009 |
| Priority date | — |
| Expiry date | Oct 18, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K36/324
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention describes compositions and methods for the management of hyperproliferative skin conditions such as psoriasis. The preferential composition contains a natural leukotriene inhibitor selected from Boswellia serrata gum resin, its extractives, isolates or derivatives in combination with a bioavailable organic selenium nutritional supplement. These compositions are administered orally and topically to the individual human or animal in need of treatment at optimal levels to manifest the desired benefits, with no untoward side effects
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.